SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
        • “Everything about the market recovery is not froth”

          Axis Mutual Fund's Jinesh Gopani on why he is betting on IT and consumption stocks

          N Mahalakshmi - March 01, 2021
        • Is it an opportune time to invest in pharma stocks?

          Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%

          June 20, 2018
        • Ray of Hope

          The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US

          Khushboo Balani - April 30, 2018
        • Virtual Identifier

          Creating and securing your digital DNA is now a few clicks away with Bitgram 

          Bhakti Tambe - March 26, 2018
        • Self Medication

          Promoter Desh Bandhu Gupta buys 88,000 shares from the market as Lupin trades near its 52-week low

          Khushboo Balani - June 02, 2017
        • Under The Weather - Part 2

          Even as it battles the US FDA, the industry has been caught off-guard by policy changes back home

          Krishna Gopalan - June 05, 2017
        • Good Timing

          Aurobindo Pharma promoters sell over 10 million shares in a market transaction valued at Rs.900 crore

          Jitendra Kumar Gupta - October 14, 2016
        • Capsule King - ACG Worldwide

          What’s the secret pill that has made ACG Worldwide the world’s second biggest capsule maker?

          Rajat Ubhaykar - May 24, 2016
        • Self-healing

          Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China

          Krishna Gopalan - March 09, 2016
        • Vivek Pandey

          Private portfolio manager Vivek Pandey is backing Wockhardt thanks to its long ANDA pipeline

          Vivek Pandey - December 10, 2015